Amgen Inc. v. F. Hoffmann-LaRoche LTD et al
Filing 752
MOTION for Leave to File Reply in Further Support of Defendants' Motion for Summary Judgment that Claim 1 of U.S. Patent No. 5,995,422 is Invalid for Indefiniteness and Lack of Written Description and Defendants' Opposition to Amgen's Alternative Motion to Strike by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: #1 Exhibit Proposed Reply in Further Support of Defendants' Motion for Summary Judgment that Claim 1 of U.S. Patent No. 5,995,422 is Invalid for Indefiniteness and Lack of Written Description and Defendants' Opposition to Amgen's Alternative Motion to Strike#2 Exhibit Decl. of Jennifer Moore in Support of Proposed Reply in Further Support of Defendants' Motion for SJ that Claim 1 of the '422 Patent is Invalid for Indefiniteness and Lack of Written Description and Defendants' Opp. to Amgen's Alternative Motion to Strike#3 Exhibit A to Declaration of Jennifer Moore#4 Exhibit B to Declaration of Jennifer Moore#5 Exhibit C to Declaration of Jennifer Moore#6 Exhibit D to Declaration of Jennifer Moore#7 Exhibit E to Declaration of Jennifer Moore#8 Exhibit F to Declaration of Jennifer Moore#9 Exhibit G to Declaration of Jennifer Moore)(Toms, Keith)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
